|
APC expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62536650805123E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.46105350040671E-13 |
| Normal-vs-Stage2 |
5.168200E-04 |
| Normal-vs-Stage3 |
9.40358901857508E-14 |
| Normal-vs-Stage4 |
1.95166105498856E-12 |
| Stage1-vs-Stage2 |
2.266000E-02 |
| Stage1-vs-Stage3 |
1.335610E-01 |
| Stage1-vs-Stage4 |
9.637200E-03 |
| Stage2-vs-Stage3 |
2.617000E-03 |
| Stage2-vs-Stage4 |
6.610900E-04 |
| Stage3-vs-Stage4 |
2.922400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.66133814775094E-16 |
| Normal-vs-AfricanAmerican |
4.93599999995542E-06 |
| Normal-vs-Asian |
2.38310005062914E-09 |
| Caucasian-vs-AfricanAmerican |
5.696200E-01 |
| Caucasian-vs-Asian |
9.091800E-01 |
| AfricanAmerican-vs-Asian |
5.288200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.02184968556685E-13 |
| Normal-vs-Female |
1.64424029946986E-12 |
| Male-vs-Female |
5.220000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.22269971924993E-11 |
| Normal-vs-Age(41-60Yrs) |
3.09197112358106E-13 |
| Normal-vs-Age(61-80Yrs) |
1.46139766954434E-11 |
| Normal-vs-Age(81-100Yrs) |
1.160260E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.854200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.418800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.026800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.637200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.219600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.768800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.984300E-02 |
| Classical-VS-Follicular |
1.317830E-01 |
| Classical-VS-Other |
2.433600E-01 |
| Classical-VS-Normal |
1.63324909152607E-12 |
| Tall-VS-Follicular |
6.677800E-03 |
| Tall-VS-Other |
7.637800E-01 |
| Tall-VS-Normal |
9.79719638749543E-11 |
| Follicular-VS-Other |
1.489040E-01 |
| Follicular-VS-Normal |
1.04580000004351E-06 |
| Other-VS-Normal |
2.406300E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.49259493653631E-11 |
| Normal-vs-N1 |
4.7972736894053E-13 |
| N0-vs-N1 |
1.276000E-02 |
|
|
